We have extensive experience in all aspects of life sciences finance, including institutional sales, capital markets, investment banking, investor and public relations, sell-side analysis, and buy-side analysis. We have an equally strong foundation in the life sciences (6 Ph.D.s on staff), which enables us to understand our clients’ R&D, regulatory, and commercial strategy. The combination of financial service and life science expertise allow us to best serve our clients’ needs.
Director, Investor Relations
William Begien has worked in institutional finance for more than 20 years. He spent the first half of his career on the fixed income side in sales and trading at Merrill Lynch and Morgan Stanley. For the last 10 years Bill has been an institutional equity salesman in Boston and New York for Caris & Company, Leerink Swann and Summer Street Research Partners. As a healthcare specialist for the last five years, Bill has a deep understanding of the sector and the buy side landscape. Bill lives in Boston and is a graduate of The University of Massachusetts at Amherst where he was a member of the varsity lacrosse team for four years.
Niki has over 15 years experience in the healthcare sector including 10 years in institutional equity sales in Europe specialising in US & European Healthcare stocks at Cowen, JP Morgan and then Fortis Bank, with a particular focus on Biotechnology companies at the latter. In 2009 she founded Aetia Ltd, a UK based specialist financial services firm offering capital raising and investor access services to private and public healthcare companies around the world, further developing her long-standing relationships with the healthcare investment community across Europe. During her career, Niki has managed numerous deal and non-deal roadshows across the UK and Europe and has a successful track record raising capital for a wide range of both public and private global life science companies at various stages of development. Prior to her investment banking career, Niki worked at Pricewaterhouse Coopers. She has a BSc in Business Management and Languages from Kings’ College, London.
Frank Gaul has 20 years of experience in equity sales, including 14 years in institutional healthcare equity sales. Most recently, he was in Equity Research Sales at Vertical Research Group, an independent equity research boutique, and previously served in similar roles at Adams, Harkness & Hill, Canaccord Adams and Leerink Swann. During his career, Mr. Gaul has established and developed relationships with many top-tier buy-side investors and sell-side analysts and bankers. Throughout his career, Mr. Gaul has managed numerous deal and non-deal roadshows in all major financial markets in the United States. He also has healthcare industry experience, having held senior sales roles at Healthcare Services Management Inc. and Epocrates (acquired by athenahealth). He received a Bachelor of Arts degree in English and Economics from Wheaton College.
Tara Hartigan has more than 17 years experience in Institutional Equity Sales. She began her career at Adams, Harkness and Hill in Boston. Following the merger with Canaccord in 2006, Tara spent 6 additional years as a Managing Director at Canaccord Genuity where she was responsible for Research Sales in the New York and Mid- Atlantic Regions. Prior to joining LifeSci Advisors, Tara was a Managing Director at Jefferies LLC and focused on Research Sales in the New York and Mid-Atlantic Regions. Tara brings a deep knowledge of the sector and has a broad reach to the buy and sell side constituencies. Tara graduated from the University of Rhode Island with a Bachelor of Arts in Anthropology.
Ed McSorley brings more than 30 years of institutional equity sales experience and a strong book of Street contacts on both the buy side and sell side. He began his institutional equity sales experience at Bache (Prudential Securities) and later worked at Dillon Read, Wasserstein Perella, Hambrecht & Quist, JP Morgan and Citigroup. Ed enlisted in the U.S. Marine Corp at 17 years old and saw service in Vietnam. He received his MBA from Fordham University and graduated from Bryant University with a B.S. in Business Administration.
Moran brings over 15 years of Investor Relations experience, having worked with Israel’s largest and most prominent private and publicly traded companies. Prior to joining LifeSci Advisors, Mrs. Meir-Beres was a senior account executive at KM Investor Relations, Israel’s first and largest IR firm, where she provided companies from a wide range of sectors ongoing investor and financial media relations advice, as well as advisory services related to public and private securities offerings, mergers and acquisitions, and crisis management. Prior to joining KM, Ms Meir-Beres was part of the IR team at Teva (NYSE: TEVA), Israel’s largest healthcare company. Moran earned her BA and Master Degree in Law from Bar-Ilan University in Israel.
Tom Rorke has more than 20 years experience in Institutional Equity Sales. He began his career in the Philadelphia Office of Wertheim and Company. Tom then spent fifteen years at Credit Suisse where he was responsible for Research Sales and Trading in the MidAtlantic, Midwest, Southeast and Canadian Regions. He also Managed Credit Suisse’s MidAtlantic Middle Markets Group for twelve of those years. Prior to joining LifeSci Advisors, Tom worked for two years at Brean Capital where he focused on Health Care Capital Markets. Tom graduated from Wake Forest University with a Bachelor of Arts in Psycholgy and Spanish.
Director, Investor Relations
Ed Salmon has more than 30 years institutional equity sales and trading experience with deep relationships on both the buy and sell side. He began his career at Smith Barney and spent 28 years at Jefferies. He received at BA at the University of Massachusetts at Amherst.